Knowing that defects in IFN signaling are associated with more severe COVID-19, Wickenhagen et al. used IFN-stimulated gene expression screening on human lung cells from which they identified a gene for 2′-5′-oligoadenylate synthetase 1 (OAS1) (see the Perspective by Schoggins). The gene discussed is OAS1; the disease is COVID-19.